Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HanAll Biopharma Reports Second Quarter 2022 Results and Provides Business Update 2022-07-29 20:00
As part of 'Operation Nasal Vaccine' to counter COVID-19 spread, ACM-001 booster vaccine administered to first subject in phase 1 safety and immunogenicity trial 2022-07-29 16:00
ZAODX World Conference on Early Detection of Cancer was successfully held in Guangzhou, China 2022-07-29 15:35
Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects 2022-07-29 12:09
The Taiwanese Startup Mindtronic AI Opens the Way to the Future of Mobility With Meta-Service Ecosystem 2022-07-29 12:01
Angel Yeast Showcases Latest Innovation in Fermentation Nutrients at Bio China 2022 2022-07-28 20:48
Ubiquitome's Liberty16 Pro ready to carve up next COVID wave 2022-07-28 20:39
ILC Dover Announces Multi-compendial Water for Injection (WFI) for Growing Biotherapeutic and Cell & Gene Therapy Markets 2022-07-28 20:00
Kira Pharmaceuticals Receives FDA Orphan Drug Designation for KP104, a Bifunctional Antibody Fusion Protein, for the Treatment of Paroxysmal Nocturnal Hemoglobinuria 2022-07-28 19:00
Transcenta to Present Interim Safety and Efficacy Data of the TST001 and Chemotherapy Combination Expansion Cohort for Claudin18.2 Positive First Line Gastric Cancer at ESMO Congress 2022 2022-07-28 08:00
Plant-Oil-Based Skincare Technology Business Available for License or Purchase 2022-07-28 05:22
Origin Agritech Receives a $35 Million Order from Muyuan Foods 2022-07-27 23:06
Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis 2022-07-27 21:30
Noul's Hydrogel Stamping is the potential core technology necessary for precise cancer diagnosis, study confirmed 2022-07-27 20:00
LoQus23 and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery 2022-07-27 16:30
Samsung Biologics Reports Second Quarter 2022 Financial Results 2022-07-27 14:43
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants 2022-07-27 07:00
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus 2022-07-26 22:09
Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America 2022-07-26 21:00
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus 2022-07-26 21:00
1 163 164 165 166 167 453